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To the Editor—The most direct way to assess the trend in
the severe acute respiratory syndrome (SARS) epidemic is
to study the number of reported cases. There are two
quantities related to reported cases: the cumulative
number and the daily number of cases. Based on these
Modelling the severe acute respiratory syndrome epidemic
observations, epidemiologists try to fit models to describe
the epidemic.
Firstly, fitting a statistical model by extrapolation not
only ignores the possibility of the effect of interventions,
Treating emerging viral infections
To the Editor—I read with interest the recently published
article on the use of plasma from a convalescent patient to
treat severe acute respiratory syndrome.1 The therapeutic
use of serum products in managing infectious disease
reminds us of the pioneering work of Robert Koch’s students,
who developed a sheep antiserum against diphtheria toxin
in 1891; a girl dying of diphtheria received the antiserum,
recovered within hours and survived.2 Since then, the strategy
of administering plasma from survivors of various epidemics
of viral illness has been used with success. Examples include
treatment of Bolivian haemorrhagic fever (during an
epidemic in the 1960s caused by Machupo virus),3 Argen-
tinian haemorrhagic fever (caused by Junin virus, a close
relative of Machupo virus),4 and Lassa fever in Nigeria.5
Reduction in mortality by giving this type of therapy has
been attributed to the immunoglobulin fraction of the
plasma—the source of neutralising antibody. A perhaps
more familiar example is the experimental use of immuno-
globin from survivors of West Nile encephalitis,6 which is
being considered for further clinical trials to manage infection
with West Nile virus.
Clearly, plasma from convalescent patients who had a
viral infection has a unique role in therapeutic medicine,
especially in the face of emerging (and often devastating)
viral infection outbreaks. Above all, these accounts make a
strong case for public health authorities to store batches of
hyperimmune plasma in case outbreaks of these diseases
strike in the future.
KM Chow, MB, ChB, MRCP
(e-mail: chow_kai_ming@alumni.cuhk.net)
Artificial Cells and Organs Research Centre
Faculty of Medicine
McGill University
Montreal, Quebec
Canada
References
1. Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute
respiratory syndrome with convalescent plasma. Hong Kong Med J
2003;9:199-201.
2. Rousell RH, Pennington JE. An historical overview of immunoglobulin
therapy. In: Yap PL, editor. Clinical applications of intravenous im-
munoglobulin therapy. Edinburgh: Churchill Livingstone; 1992:1-15.
3. Stinebaugh BJ, Schloeder FX, Johnson KM, Mackenzie RB, Entwisle
G, De Alba E. Bolivian hemorrhagic fever. A report of four cases. Am
J Med 1966;40:217-30.
4. Ruggiero HA, Perez Isquierdo F, Milani HA, et al. Treatment of
Argentine hemorrhagic fever with convalescent’s plasma. 4433 cases
[in French]. Presse Med 1986;15:2239-42.
5. Frame JD, Verbrugge GP, Gill RG, Pinneo L. The use of Lassa fever
convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg 1984;78:
319-24.
6. Solomon T, Ooi MH, Beasley DW, Mallewa M. West Nile encephalitis.
BMJ 2003;326:865-9.
To the Editor—We thank Drs Chow, Burnouf and Rado-
sevich for their valuable comments. Dr Chow provided
important examples of when convalescent plasma has been
used to treat other severe viral illnesses. Drs Burnouf and
Radosevich suggested ways of improving convalescent
plasma therapy. Our institution has analysed more than 20
patients who received convalescent plasma for severe acute
respiratory syndrome. Among patients who had pulsed
methylprednisolone for more than 1.5 g, those receiving
concomitant plasma had better survival and earlier discharge
from hospital (unpublished data).
Authors’ reply
VWS Wong, MB, ChB, MRCP
(e-mail: wonws1@yahoo.com.hk)
D Dai, MB, BS, FRCP
AKL Wu, MB, ChB, MRCP
JJY Sung, MD, PhD
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
Prince of Wales Hospital
Shatin
New Territories
Hong Kong
Hong Kong Med J Vol 9 No 4 August 2003      311
but also ignores unique features of the transmission of the
epidemic. That is, useful information concerning the
incubation period, the time between infection and onset of
disease when there is contact between susceptible and
infectious individuals, is not fully utilised.
Secondly, some extraordinary events, such as the major
outbreak in the housing estate (Amoy Gardens) in Hong
Kong, will greatly distort the shape of the original curve.
This will result in a poor fit of the statistical model.
Furthermore, initially epidemics tend to experience a period
of exponential growth that then levels off when more than
half of the population is infected. Modelling the epidemic
by extrapolation cannot capture this characteristic. The use
of an exponential model or a linear model has also been
criticised for these reasons by Razum et al.1
Alternatively, there are epidemic models that are spec-
ially designed for modelling infectious disease.2-4 However,
the application of such models requires detailed information
including, for example, the time of infection and the number
of infectious individuals over the course of epidemic. This
information is usually incomplete and/or unavailable.
As suggested by Razum et al,1 studying the daily number
of reported SARS cases is easy for the public to understand,
and can indirectly show the change in the reproductive
number (R0), defined as the average number of secondary
cases generated by one primary case in a susceptible
population.2,3 However, due to the incubation period, there
is a time lag between the day of infection and the day of
reporting. As a result, the epidemic curve of the daily number
of SARS cases may not adequately monitor the change in
R0. Further, as there is variation in the length of the incuba-
tion period, people reported on the same day may have been
infected on different days.
We propose the back-projection approach to be used to
reconstruct the infection curve, based on the daily reported
number of cases and an estimated incubation period.5-7 The
SARS infection curve for Hong Kong up to 6 June 2003 was
reconstructed using the back-projection method. The
estimated curve and the fitted daily reported number of cases
are shown in Fig a and b. The estimated infection curve is
easy to interpret and the effect of major events on the spread
of the epidemic can be readily identified.
Modelling the SARS epidemic using a simple extra-
polation model is definitely inaccurate, while a complicated
stochastic epidemic model may not be feasible. The back-
projection method is thus preferred. Further, the
assumptions made for each model need to be explicitly
stated when the model is used in order to avoid any mis-
leading conclusions.
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Fig. (b) Observed and fitted daily number of severe acute
respiratory syndrome reported cases in Hong Kong
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Fig. (a) Estimated daily number of infection of severe acute
respiratory syndrome in Hong Kong
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